384 related articles for article (PubMed ID: 27333182)
1. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
[TBL] [Abstract][Full Text] [Related]
2. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
3. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB
Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice.
Kamimura R; Hossain MZ; Unno S; Ando H; Masuda Y; Takahashi K; Otake M; Saito I; Kitagawa J
J Oral Sci; 2018 Mar; 60(1):37-44. PubMed ID: 29503395
[TBL] [Abstract][Full Text] [Related]
6. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
Thomas A; Okine BN; Finn DP; Masocha W
Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.
Long JZ; Nomura DK; Cravatt BF
Chem Biol; 2009 Jul; 16(7):744-53. PubMed ID: 19635411
[TBL] [Abstract][Full Text] [Related]
8. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.
Woodhams SG; Wong A; Barrett DA; Bennett AJ; Chapman V; Alexander SP
Br J Pharmacol; 2012 Dec; 167(8):1609-19. PubMed ID: 22924700
[TBL] [Abstract][Full Text] [Related]
9. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
Costola-de-Souza C; Ribeiro A; Ferraz-de-Paula V; Calefi AS; Aloia TP; Gimenes-Júnior JA; de Almeida VI; Pinheiro ML; Palermo-Neto J
PLoS One; 2013; 8(10):e77706. PubMed ID: 24204926
[TBL] [Abstract][Full Text] [Related]
10. Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.
Nass SR; Steele FF; Ware TB; Libby AH; Hsu KL; Kinsey SG
Cannabis Cannabinoid Res; 2021 Jun; 6(3):233-241. PubMed ID: 34042520
[No Abstract] [Full Text] [Related]
11. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
Wang J; Zhang X; Yang C; Zhao S
Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
[TBL] [Abstract][Full Text] [Related]
12. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
Hashem J; Hu M; Zhang J; Gao F; Chen C
Mol Neurobiol; 2021 Aug; 58(8):4122-4133. PubMed ID: 33939165
[TBL] [Abstract][Full Text] [Related]
15. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
Pan B; Wang W; Long JZ; Sun D; Hillard CJ; Cravatt BF; Liu QS
J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
[TBL] [Abstract][Full Text] [Related]
17. Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase.
Liu X; Chen Y; Vickstrom CR; Li Y; Viader A; Cravatt BF; Liu QS
Sci Rep; 2016 Oct; 6():35829. PubMed ID: 27775008
[TBL] [Abstract][Full Text] [Related]
18. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.
Ignatowska-Jankowska BM; Ghosh S; Crowe MS; Kinsey SG; Niphakis MJ; Abdullah RA; Tao Q; O' Neal ST; Walentiny DM; Wiley JL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2014 Mar; 171(6):1392-407. PubMed ID: 23848221
[TBL] [Abstract][Full Text] [Related]
19. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]